LOAME
Lombard Odier Asset Management (Europe) Portfolio holdings
AUM
$1.39B
1-Year Return
17.73%
This Quarter Return
+5.81%
1 Year Return
+17.73%
3 Year Return
+55.88%
5 Year Return
+84.73%
10 Year Return
–
AUM
$2.34B
AUM Growth
+$420M
(+22%)
Cap. Flow
-$807M
Cap. Flow
% of AUM
-34.43%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
315
New
26
Increased
68
Reduced
104
Closed
32
Top Buys
| 1 |
Sensata Technologies
ST
|
$18.1M |
| 2 |
Tetra Tech
TTEK
|
$11.9M |
| 3 |
ON Semiconductor
ON
|
$11.7M |
| 4 |
S&P Global
SPGI
|
$11.6M |
| 5 |
SolarEdge
SEDG
|
$9.15M |
Top Sells
| 1 |
Generac Holdings
GNRC
|
$13.4M |
| 2 |
Zebra Technologies
ZBRA
|
$10.7M |
| 3 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
$10.4M |
| 4 |
Sunrun
RUN
|
$9.82M |
| 5 |
AES
AES
|
$9.22M |
Sector Composition
| 1 | Technology | 15.31% |
| 2 | Healthcare | 7.97% |
| 3 | Industrials | 7.49% |
| 4 | Financials | 5.07% |
| 5 | Consumer Staples | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
IQVIA
IQV
$31.9B
| $1.15M | 0.05% |
5,600
-9,884
| -64% | -$2.03M |
|
177
Halozyme
HALO
$8.76B
| $1.11M | 0.05% |
19,500
-500
| -3% | -$28.5K |
|
|
NXGN
178
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.1M | 0.04% |
58,600
-6,400
| -10% | -$120K |
|
179
DocuSign
DOCU
$16.1B
| $1.04M | 0.04% |
18,851
-1,611
| -8% | -$89.3K |
|
180
Ford
F
$46.7B
| $1.04M | 0.04% |
89,249
-3,641
| -4% | -$42.3K |
|
181
Alcoa
AA
$8.24B
| $981K | 0.04% |
21,584
-806
| -4% | -$36.6K |
|
182
Hain Celestial
HAIN
$164M
| $891K | 0.04% |
55,050
+18,673
| +51% | +$302K |
|
183
Insulet
PODD
$24.5B
| $883K | 0.04% |
3,000
-400
| -12% | -$118K |
|
184
Quest Diagnostics
DGX
$20.5B
| $860K | 0.04% |
5,500
+900
| +20% | +$141K |
|
185
Intuitive Surgical
ISRG
$167B
| $849K | 0.03% |
3,200
| – | – |
|
186
Hologic
HOLX
$14.8B
| $845K | 0.03% |
11,300
+1,300
| +13% | +$97.3K |
|
187
CVS Health
CVS
$93.6B
| $833K | 0.03% |
8,944
-6,901
| -44% | -$643K |
|
188
Charles River Laboratories
CRL
$8.07B
| $828K | 0.03% |
3,800
-100
| -3% | -$21.8K |
|
189
Lindsay Corp
LNN
$1.53B
| $822K | 0.03% |
5,045
+2,919
| +137% | +$475K |
|
190
Calavo Growers
CVGW
$485M
| $755K | 0.03% |
25,692
-59,221
| -70% | -$1.74M |
|
|
STKL
191
SunOpta
STKL
$779M
| $655K | 0.03% |
77,610
+48,636
| +168% | +$410K |
|
192
Omnicell
OMCL
$1.47B
| $605K | 0.02% |
12,000
+3,500
| +41% | +$176K |
|
193
Masimo
MASI
$8B
| $577K | 0.02% |
3,900
+1,450
| +59% | +$215K |
|
194
Evolent Health
EVH
$1.11B
| $576K | 0.02% |
20,500
-4,500
| -18% | -$126K |
|
195
Maravai LifeSciences
MRVI
$363M
| $572K | 0.02% |
40,000
-3,000
| -7% | -$42.9K |
|
196
ResMed
RMD
$40.6B
| $562K | 0.02% |
2,700
-300
| -10% | -$62.4K |
|
197
Garmin
GRMN
$45.7B
| $554K | 0.02% |
+6,000
| New | +$554K |
|
198
GoodRx Holdings
GDRX
$1.39B
| $550K | 0.02% |
118,000
+33,000
| +39% | +$154K |
|
199
HealthEquity
HQY
$7.88B
| $546K | 0.02% |
8,850
-150
| -2% | -$9.25K |
|
200
Privia Health
PRVA
$2.86B
| $545K | 0.02% |
24,000
+15,000
| +167% | +$341K |
|